Transdermal Electrochemical Monitoring of Glucose via High-Density Silicon Microneedle Array Patch

Current technology for blood glucose level monitoring is mainly based on the invasive finger-prick extraction of a small drop of blood using a lancet and measured via a handheld glucometer, which is not conducive to continuous measurements. Interstitial fluid (ISF) is gaining attention as an alternative biofluid. Its biochemical composition is very similar to that of blood and it can be monitored in a continuous manner via minimally invasive methods that cause no pain and minimize any risk of infection. Herein, a microneedle array (MNA) based transdermal sensing system for the pain free monitoring of ISF glucose is presented. High-density silicon microneedles (approximate to 9500 microneedles cm(-2)) are used to prepare a three-electrode patch for the electrochemical monitoring of glucose. The MNA glucose patch shows very good selectivity when tested in artificial ISF, with a sensitivity of 0.1622 mu A mm(-1) cm(-2) and a detection limit of 0.66 mm. In vivo application of the microneedle array in mice shows that the ISF glucose concentrations obtained with the MNA sensor gave very good correlation with the blood glucose levels determined with a commercial glucometer. This microneedle-based sensing system hence provides an alternative transdermal diagnostic tool to the invasive existing techniques.

Automated summary

The microneedle array-based transdermal sensing system offers a pain-free alternative for continuous glucose monitoring of interstitial fluid. The system demonstrates good selectivity and sensitivity, with accurate correlation to blood glucose levels measured by a commercial glucometer.